We are live on
!
Find out more
Los Angeles Capital Management Portfolio holdings
AUM
$27.2B
1-Year Est. Return
43.16%
This Fund
S&P 500
This Quarter
Est. Return
-3.12%
1 Year Est. Return
+43.16%
3 Year Est. Return
+177.72%
5 Year Est. Return
+262.7%
10 Year Est. Return
+1,121.27%
AUM
$19.3B
AUM Growth
-$1.05B
(-5.2%)
Cap. Flow
-$77.1M
Cap. Flow
% of AUM
-0.4%
Top 10 Holdings %
Top 10 Hldgs %
26.03%
Holding
1,444
New
138
Increased
405
Reduced
531
Closed
234
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Broadcom
AVGO
|
+$224M |
| 2 |
Brown-Forman Class B
BF.B
|
+$140M |
| 3 |
UnitedHealth
UNH
|
+$132M |
| 4 |
Monolithic Power Systems
MPWR
|
+$108M |
| 5 |
Oracle
ORCL
|
+$97.8M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alphabet (Google) Class C
GOOG
|
+$134M |
| 2 |
Alphabet (Google) Class A
GOOGL
|
+$122M |
| 3 |
Micron Technology
MU
|
+$122M |
| 4 |
Pfizer
PFE
|
+$120M |
| 5 |
Microsoft
MSFT
|
+$117M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 31.43% |
| 2 | Healthcare | 14.49% |
| 3 | Financials | 11.62% |
| 4 | Consumer Discretionary | 10.92% |
| 5 | Industrials | 8.57% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
526
RLI Corp
RLI
$5.81B
| $1.8M | 0.01% |
35,106
+28,260
| +413% | +$1.58M |
|
527
Metropolitan Bank Holding Corp
MCB
$1.17B
| $1.79M | 0.01% |
27,830
+4,131
| +17% | +$293K |
|
528
Simply Good Foods
SMPL
$970M
| $1.78M | 0.01% |
+55,656
| New | +$1.83M |
|
529
Grab
GRAB
$14.8B
| $1.77M | 0.01% |
674,923
+236,932
| +54% | +$718K |
|
|
AERI
530
DELISTED
Aerie Pharmaceuticals
AERI
| $1.76M | 0.01% |
116,560
+71,907
| +161% | +$836K |
|
531
Centrus Energy
LEU
$3.72B
| $1.76M | 0.01% |
43,029
-4,651
| -10% | -$179K |
|
|
HTBK
532
DELISTED
Heritage Commerce
HTBK
| $1.75M | 0.01% |
154,299
+123,540
| +402% | +$1.42M |
|
533
Hancock Whitney
HWC
$6.36B
| $1.74M | 0.01% |
37,931
-1,890
| -5% | -$90.9K |
|
534
Kinsale Capital Group
KNSL
$8.5B
| $1.74M | 0.01% |
6,796
-200
| -3% | -$49.8K |
|
535
Alkermes
ALKS
$8.34B
| $1.74M | 0.01% |
77,696
+62,695
| +418% | +$1.63M |
|
|
CCRN
536
DELISTED
Cross Country Healthcare
CCRN
| $1.73M | 0.01% |
61,111
-54,020
| -47% | -$1.39M |
|
537
Comcast
CMCSA
$91.8B
| $1.72M | 0.01% |
58,635
-126,107
| -68% | -$4.72M |
|
538
Sprout Social
SPT
$579M
| $1.72M | 0.01% |
28,352
+5
| +0% | +$301 |
|
|
OLPX
539
DELISTED
Olaplex Holdings
OLPX
| $1.72M | 0.01% |
179,992
-13,725
| -7% | -$197K |
|
540
Boise Cascade
BCC
$2.92B
| $1.72M | 0.01% |
28,893
-900
| -3% | -$57.9K |
|
|
RYZ
541
Ryerson Holding Corp
RYZ
$1.49B
| $1.71M | 0.01% |
66,330
+36,760
| +124% | +$978K |
|
542
Antero Midstream
AM
$10.5B
| $1.7M | 0.01% |
185,520
-251,090
| -58% | -$2.47M |
|
|
LOVE
543
LoveSac
LOVE
$260M
| $1.69M | 0.01% |
82,880
-460
| -0.6% | -$14.1K |
|
544
Regional Management Corp
RM
$299M
| $1.69M | 0.01% |
60,230
-7,015
| -10% | -$255K |
|
545
SunCoke Energy
SXC
$783M
| $1.69M | 0.01% |
290,250
| – | – |
|
546
Barrett Business Services
BBSI
$783M
| $1.67M | 0.01% |
85,820
-28,540
| -25% | -$570K |
|
|
ITOS
547
DELISTED
iTeos Therapeutics
ITOS
| $1.67M | 0.01% |
87,826
-36,971
| -30% | -$852K |
|
548
StoneCo
STNE
$2.47B
| $1.67M | 0.01% |
175,596
-799,140
| -82% | -$7.65M |
|
549
Stryker
SYK
$131B
| $1.66M | 0.01% |
8,205
+4,054
| +98% | +$853K |
|
550
Archer Daniels Midland
ADM
$38.8B
| $1.66M | 0.01% |
20,573
-146
| -0.7% | -$12K |
|
Similar funds
FDCDDQ
WP
N
PCH
VAI
Los Angeles Capital Management's Q3 2022 Portfolio in Review
As of Q3 2022, Los Angeles Capital Management held 1,444 positions worth $19.3B, down 5.2% from $20.3B the previous quarter. Its ten largest holdings account for 26% of the portfolio.
Los Angeles Capital Management's Q3 2022 filing shows 138 new, 405 increased, 531 reduced and 234 closed positions. Its largest new stake was Neurocrine Biosciences: 791,966 shares worth $84.1M. The largest sale was Alphabet (Google) Class C, an estimated $134M.
By sector, the portfolio is most concentrated in Technology at 31% of assets, down from 32% a quarter earlier, followed by Healthcare and Financials.
- Los Angeles Capital Management's largest Q3 2022 buy was Neurocrine Biosciences: 791,966 shares worth $84.1M.
- Los Angeles Capital Management added most to Broadcom in Q3 2022, an estimated $224M increase.
- Los Angeles Capital Management's biggest Q3 2022 reduction was Alphabet (Google) Class C, cutting an estimated $134M.
- Los Angeles Capital Management fully exited D.R. Horton in Q3 2022, selling an estimated $37.1M.
- Los Angeles Capital Management's ten largest holdings make up 26% of its $19.3B portfolio in Q3 2022.
- Los Angeles Capital Management opened 138 new positions and closed 234 in Q3 2022.
- Los Angeles Capital Management's portfolio value fell 5.2% quarter-over-quarter to $19.3B.
Based on Los Angeles Capital Management's 13F filing for Q3 2022, filed 2 Nov 2022.